Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials January 17, 2025
ExpreS2ion announces approval to initiate a Phase I clinical trial of ES2B-C001, its novel therapeutic vaccine, being developed for HER2-expressing breast cancer December 2, 2024
NIH Scientists Find That Breast Cancer Protection From Pregnancy Starts Decades Later November 2, 2024